Respirology
Expert Brief 5: Differences in Dual Bronchodilators (LAMA/LABA)
COPD is one of the most common conditions seen in primary care. With the many options that can be considered for these patients, it is important for primary care clinicians be aware of the current evidence to guide treatment. This series will review current evidence, compare it to current guidelines and apply it to common cases seen in clinical practice.
This program has received an unrestricted educational grant or in-kind support from GSK.
DURATION
15 min
PROFESSION
Physician
# OF CREDITS
0.3
ACCREDITATION
Mainpro+
EXPIRY DATE
2023-09-30
COPD is one of the most common conditions seen in primary care. With the many options that can be considered for these patients, it is important for primary care clinicians be aware of the current evidence to guide treatment. This series will review current evidence, compare it to current guidelines and apply it to common cases seen in clinical practice.
This program has received an unrestricted educational grant or in-kind support from GSK.
Faculty
John Axler, MD, LMCC, CCFP, FCFP
Andre Belanger, MD, CFPC
Jeff Habert, MD, CCFP, FCFP
Sol Stern, Bsc, MD, MCFP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Review Canadian Thoracic Society COPD guideline recommendations for patients with significant symptom burden and low risk of AECOPD
- Discuss the evidence regarding the differences in response and safety with two dual bronchodilators (LAMA/LABA)
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.3 Mainpro+ credits.
This program is developed in collaboration with ICEBM.